Hepatitis B care pathway in Jordan: current situation, gaps and recommended actions.
Jordan
awareness
diagnosis
epidemiology
hepatitis B
treatment
Journal
Journal of virus eradication
ISSN: 2055-6640
Titre abrégé: J Virus Erad
Pays: England
ID NLM: 101654142
Informations de publication
Date de publication:
20 Feb 2020
20 Feb 2020
Historique:
entrez:
17
3
2020
pubmed:
17
3
2020
medline:
17
3
2020
Statut:
epublish
Résumé
Hepatitis B virus (HBV) infection remains a worldwide public health problem. The last major review of the HBV care pathway in the Middle East was published in 2011. This article aims to assess the current situation of the HBV care pathway in Jordan, identify gaps and barriers and recommend initiatives that could be taken to improve disease management across all stages of the care pathway. A Delphi process was used between February and October 2017, including a literature review (PubMed and Google Scholar) for published articles on HBV in Jordan, followed by individual interviews with various healthcare professionals and group discussions with leading Jordanian hepatologists and gastroenterologists to provide context to the results of the literature review. The national prevalence of HBV is estimated to be around 2.4% and has declined from 9.9% in the pre-vaccination era. There is limited data on the burden of HBV-related hepatocellular carcinoma in the country. Awareness of various aspects of the disease is considered low among the general population and medium among primary care providers. There are several mandated national screening structures, however, established protocols for those that test positive and subsequent linkage-to-care are not optimal. In conclusion, significant improvements have been made in the past 30 years in Jordan in terms of decline in HBV prevalence. However, efforts must be made by all key stakeholders to optimise screening and linkage-to-care of patients and reduce both morbidity and mortality in the country.
Types de publication
Editorial
Langues
eng
Pagination
1-6Informations de copyright
© 2020 The Authors. Journal of Virus Eradication published by Mediscript.
Références
J Dent Educ. 2005 Jun;69(6):693-8
pubmed: 15947216
J Trop Pediatr. 2001 Aug;47(4):239-42
pubmed: 11523766
Int Dent J. 2008 Oct;58(5):231-6
pubmed: 19009988
Infect Dis Obstet Gynecol. 2002;10(3):127-32
pubmed: 12625968
World J Gastroenterol. 2008 Dec 21;14(47):7231-4
pubmed: 19084939
Quintessence Int. 2008 Apr;39(4):e147-51
pubmed: 19081891
J Viral Hepat. 2012 Jan;19(1):9-22
pubmed: 22187943
J Pathol. 2015 Jan;235(2):355-67
pubmed: 25196558
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Am J Epidemiol. 1990 Aug;132(2):220-32
pubmed: 2372003
Hepatology. 2016 Jan;63(1):261-83
pubmed: 26566064
Qatar Med J. 2017 Apr 21;2016(2):14
pubmed: 28534006
Hepatology. 2008 Apr;47(4):1108-17
pubmed: 18318043
Gastroenterology. 2012 May;142(6):1264-1273.e1
pubmed: 22537432
Lancet. 2017 Sep 16;390(10100):1211-1259
pubmed: 28919117
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403
pubmed: 29599078
Can J Gastroenterol. 2012 Jul;26(7):445-51
pubmed: 22803020
Am J Infect Control. 2006 May;34(4):218-22
pubmed: 16679180
Asian Pac J Cancer Prev. 2015;16(1):265-70
pubmed: 25640363
East Mediterr Health J. 2007 May-Jun;13(3):654-63
pubmed: 17687839
Saudi J Kidney Dis Transpl. 2008 Mar;19(2):260-7
pubmed: 18310881
Hepatogastroenterology. 2012 Jun;59(116):1036-42
pubmed: 22328288
Int Nurs Rev. 2008 Jun;55(2):142-7
pubmed: 18477097
Clin Gastroenterol Hepatol. 2012 Mar;10(3):291-6
pubmed: 22019793
J Dent Educ. 2007 Sep;71(9):1223-7
pubmed: 17761630
J Hepatol. 2012 Jul;57(1):167-85
pubmed: 22436845
Aliment Pharmacol Ther. 2015 Feb;41(3):310-9
pubmed: 25982037